Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatments

References

• Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571–607.
   PubMed Web of Science ®Google Scholar
• Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet (London, England). 2017;389(10080):1756–1770.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431–440.
   Web of Science ®Google Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–1794.
   PubMed Web of Science ®Google Scholar
• Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4(4):431–437.
   PubMed Web of Science ®Google Scholar
• Campieri M, Adamo S, Valpiani D, et al. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. Aliment Pharmacol Ther. 2003;17(12):1471–1480.
   Web of Science ®Google Scholar
• Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (London, England). 1974;1(7866):1067–1070.
   PubMed Web of Science ®Google Scholar
• Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6(10):965–990.
   Web of Science ®Google Scholar
• Gomollon F, Garcia-Lopez S, Sicilia B, et al. Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU. Gastroenterol Hepatol. 2013;36(2):104–114.
   Web of Science ®Google Scholar
• Faubion WA Jr., Loftus EV Jr., Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121(2):255–260.
   Web of Science ®Google Scholar
• Ho GT, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006;24(2):319–330.
   Web of Science ®Google Scholar
• Li J, Wang F, Zhang HJ, et al. Corticosteroid therapy in ulcerative colitis: clinical response and predictors. World Journal of Gastroenterology. 2015;21(10):3005–3015.
   Web of Science ®Google Scholar
• Khan N, Abbas A, Williamson A, et al. Prevalence of corticosteroids use and disease course after initial steroid exposure in ulcerative colitis. Digestive Diseases and Sciences. 2013;58(10):2963–2969.
   Web of Science ®Google Scholar
• Garcia-Planella E, Mañosa M, Van Domselaar M, et al. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Dig Liver Dis. 2012;44(3):206–210.
   PubMedGoogle Scholar
• Khan N, Patel D, Shah Y, et al. A novel user-friendly model to predict corticosteroid utilization in newly diagnosed patients with ulcerative colitis. Inflammatory Bowel Diseases. 2017;23(6):991–997.
   PubMed Web of Science ®Google Scholar
• Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut. 1996;38(6):905–910.
   PubMed Web of Science ®Google Scholar
• Ventham NT, Kalla R, Kennedy NA, et al. Predicting outcomes in acute severe ulcerative colitis. Expert Review of Gastroenterology & Hepatology. 2015;9(4):405–415.
   Web of Science ®Google Scholar
• Meyers S, Lerer PK, Feuer EJ, et al. Predicting the outcome of corticoid therapy for acute ulcerative colitis: results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol. 1987;9(1):50–54.
   PubMed Web of Science ®Google Scholar
• Lindgren SC, Flood LM, Kilander AF, et al. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol. 1998;10(10):831–835.
   Web of Science ®Google Scholar
• Ho GT, Mowat C, Goddard CJ, et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19(10):1079–1087.
   Web of Science ®Google Scholar
• Barreiro-Alonso E, Saro-Gismera C, Sanchez M. Predictors of the response to corticosteroids treatment in the ulcerative colitis. United European Gastroenterology Journal (24th UEG Week 2016). 2016;4(5S):A642.
   Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170: 2-6. discussion 16–19.
   PubMedGoogle Scholar
• Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6(10):991–\1030.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A. Age distribution of IBD hospitalization. Inflammatory Bowel Diseases. 2010;16(3):452–457.
   Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–753.
   Web of Science ®Google Scholar
• Järnerot G, Rolny P, Sandberg-Gertzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology. 1985;89(5):1005–1013.
   PubMed Web of Science ®Google Scholar
• Khan NH, Almukhtar RM, Cole EB, et al. Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long-term course of the disease – a nationwide study of 1035 patients. Aliment Pharmacol Ther. 2014;40(4):374–381.
   Web of Science ®Google Scholar